XL-647
- CAS No.
- 781613-23-8
- Chemical Name:
- XL-647
- Synonyms
- KD-019;XL-647;Tesevatinib;XL647 /EXEL-7647;Tesevatinib(XL647);EXEL-7647;XL-647;XL 647;Rel-N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)methoxy)quinazolin-4-amine;N-(3,4-dichloro-2-fluorophenyl)-6-Methoxy-7-(((3aR,6aS)-2-Methyloctahydrocyclopenta[c]pyrrol-5-yl)Methoxy)quinazolin-4-aMine;N-(3,4-Dichloro-2-fluorophenyl)-6-methoxy-7-(((3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)methoxy)quinazolin-4-amine;4-Quinazolinamine, N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-[[(3aα,5β,6aα)-octahydro-2-methylcyclopenta[c]pyrrol-5-yl]methoxy]-
- CBNumber:
- CB82628532
- Molecular Formula:
- C24H25Cl2FN4O2
- Molecular Weight:
- 491.3853032
- MDL Number:
- MFCD23726660
- MOL File:
- 781613-23-8.mol
Boiling point | 567.9±50.0 °C(Predicted) |
---|---|
Density | 1.356 |
storage temp. | Store at -20°C |
solubility | DMF: 10 mg/ml; DMSO: 10 mg/ml; Ethanol: 10 mg/ml |
form | A solid |
pka | 10.16±0.40(Predicted) |
FDA UNII | F6XM2TN5A1 |
NCI Drug Dictionary | tesevatinib |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS05 |
---|---|
Signal word | Danger |
Hazard statements | H314 |
Precautionary statements | P260-P280-P303+P361+P353-P301+P330+P331-P304+P340+P310-P305+P351+P338+P310 |
XL-647 price More Price(9)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Cayman Chemical | 27049 | XL647 | 781613-23-8 | 1mg | $97 | 2024-03-01 | Buy |
Cayman Chemical | 27049 | XL647 | 781613-23-8 | 10mg | $672 | 2024-03-01 | Buy |
Cayman Chemical | 27049 | XL647 | 781613-23-8 | 5mg | $360 | 2024-03-01 | Buy |
ChemScene | CS-3666 | Tesevatinib 99.21% | 781613-23-8 | 5mg | $360 | 2021-12-16 | Buy |
ChemScene | CS-3666 | Tesevatinib 99.21% | 781613-23-8 | 10mg | $648 | 2021-12-16 | Buy |
XL-647 Chemical Properties,Uses,Production
Uses
XL 647 is a potent and selective EGFR phosphorylation inhibitor and may be used in the treatment of patients suffering from lung cancer. Orally available, multi-target tyrosine kinase inhibitor.
Definition
ChEBI: Tesevatinib is a member of the class of quinazolines that is quinazoline substituted by (3,4-dichloro-2-fluorophenyl)amino, methoxy, and [(3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl]methoxy groups at positions 4, 6 and 7, respectively. It is a multi-target tyrosine kinase inhibitor of EGFR, ErbB2, KDR, Flt4 and EphB4 and exhibits anti-cancer properties. It has a role as an antineoplastic agent, an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor and an epidermal growth factor receptor antagonist. It is a member of quinazolines, an aromatic ether, a member of monofluorobenzenes, a dichlorobenzene, a secondary amino compound, a diether and a tertiary amino compound.
XL-647 Preparation Products And Raw materials
Raw materials
Preparation Products
XL-647 Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
career henan chemical co | +86-0371-86658258 | sales@coreychem.com | China | 29914 | 58 |
BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19553 | 58 |
Chongqing Chemdad Co., Ltd | +86-023-61398051 +8613650506873 | sales@chemdad.com | China | 39916 | 58 |
Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471 | sales@sarms4muscle.com | China | 10523 | 58 |
changzhou huayang technology co., ltd | +8615250961469 | 2571773637@qq.com | China | 9821 | 58 |
Aceschem Inc. | +1-817863-6948 +1-(817)863-6948 | sales@aceschem.com | United States | 19639 | 58 |
Amadis Chemical Company Limited | 571-89925085 | sales@amadischem.com | China | 131981 | 58 |
Jiangsu yize medical technology co. LTD | 18550739526 | 3394205705@qq.com | China | 2011 | 58 |
Shanghai Boyle Chemical Co., Ltd. | sales@boylechem.com | China | 2923 | 55 | |
Chembest Research Laboratories Limited | 021-20908456 | sales@BioChemBest.com | China | 6011 | 61 |